129 related articles for article (PubMed ID: 2632088)
1. 5-Fluorouracil derivative. XVII. Synthesis and antitumor activity of 5'-O-acyl-5-fluorouridines.
Ozaki S; Akiyama T; Ike Y; Mori H; Hoshi A
Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3405-8. PubMed ID: 2632088
[TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil derivatives. XX. Synthesis and antitumor activity of 5'-O-unsaturated acyl-5-fluorouridines.
Ozaki S; Akiyama T; Morita T; Kumegawa M; Nagase T; Uehara N; Hoshi A
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3164-6. PubMed ID: 2085902
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of 5'-substituted 5-fluoropyrimidine nucleosides.
Ajmera S; Danenberg PV
J Med Chem; 1982 Aug; 25(8):999-1002. PubMed ID: 7120290
[TBL] [Abstract][Full Text] [Related]
4. Nucleosides and nucleotides--CXXXVII. Antitumor phospholipids with 5-fluorouridine as a cytotoxic polar-head: synthesis of 5'-phosphatidyl-5-fluorouridines by phospholipase D-catalyzed transphosphatidylation.
Shuto S; Itoh H; Sakai A; Nakagami K; Imamura S; Matsuda A
Bioorg Med Chem; 1995 Mar; 3(3):235-43. PubMed ID: 7606385
[TBL] [Abstract][Full Text] [Related]
5. 5-Fluorouracil derivatives. XII. Synthesis and antitumor activity of alpha-alkylthiomethyl-, alpha-alkylsulfinylmethyl-, alpha-alkylsulfonylmethyl-, and alpha-acylthiomethyl-5-fluorouracils.
Ozaki S; Nagase T; Tamai H; Mori H; Hoshi A; Iigo M
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3894-7. PubMed ID: 3435984
[No Abstract] [Full Text] [Related]
6. Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25.
Sakamoto O; Mori H; Kitaichi K; Koda A; Kato T
Jpn J Pharmacol; 1992 Aug; 59(4):469-76. PubMed ID: 1434142
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and activities of antitumor agents.
Suami T; Machinami T; Hisamatsu T
J Med Chem; 1979 Mar; 22(3):247-50. PubMed ID: 423206
[TBL] [Abstract][Full Text] [Related]
8. Uracil derivatives. V. Syntheses and growth-inhibitory activity against L-1210 cells of 5-substituted 2'-deoxyuridines and orotidine derivatives.
Okada J; Nakano K; Miyake H
Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):856-64. PubMed ID: 4017129
[No Abstract] [Full Text] [Related]
9. Antitumor activity of 1-acyloxymethyl derivatives of 5-fluorouracil against L1210 leukemia.
Hoshi A; Inomata M; Kanzawa F; Iigo M; Kuretani K
J Pharmacobiodyn; 1982 Mar; 5(3):208-12. PubMed ID: 7097489
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil derivatives. XXII. Synthesis and antitumor activities of 1-carbamoyl-5-fluorouracils.
Ozaki S; Kong X; Watanabe Y; Hoshiko T; Koga T; Ogasawara T; Takizawa T; Fujisawa H; Iigo M; Hoshi A
Chem Pharm Bull (Tokyo); 1997 Aug; 45(8):1372-5. PubMed ID: 9301037
[TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil derivatives. IX. Synthesis and antitumor activities of (alkylthio)carbonyl-5-fluorouracils.
Hoshiko T; Ozaki S; Watanabe Y; Ogasawara T; Yamauchi S; Fujiwara K; Hoshi A; Iigo M
Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2832-7. PubMed ID: 4085042
[No Abstract] [Full Text] [Related]
12. Studies on antitumor agents. 8. Antitumor activities of O-alkyl derivatives of 2'-deoxy-5-(trifluoromethyl)uridine and 2'-deoxy-5-fluorouridine.
Yamashita J; Takeda S; Matsumoto H; Unemi N; Yasumoto M
J Med Chem; 1989 Jan; 32(1):136-9. PubMed ID: 2521251
[TBL] [Abstract][Full Text] [Related]
13. Novel derivatives of 5-fluorouridine and 5-fluorouracil having potent antitumor and lower immunosuppressive activities.
Mori H; Sakamoto O; Kitaichi K; Koda A; Kita J
Jpn J Pharmacol; 1992 Mar; 58(3):269-82. PubMed ID: 1513076
[TBL] [Abstract][Full Text] [Related]
14. Aminopyrimidines and derivatives. XXI. Synthesis of 5-acyl(4-beta-D-glycopyranosylamino)pyrimidine derivatives as potential anticancer agents.
Negrillo J; Nogueras M; Sánchez A; Melgarejo M
Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):386-93. PubMed ID: 3378299
[No Abstract] [Full Text] [Related]
15. Synergistic antitumor effect of fluoropyrimidines and polyinosinic-polycytidylic acid against L1210 leukemia.
Iigo M; Chapekar MS; Glazer RI
Cancer Res; 1985 Sep; 45(9):4039-42. PubMed ID: 2411395
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of Pt(II) complexes containing diaminocarboxylates and their ester derivatives.
Noji M; Hanamura S; Suzuki K; Tashiro T; Kidani Y
Chem Pharm Bull (Tokyo); 1986 Jun; 34(6):2487-93. PubMed ID: 3769066
[No Abstract] [Full Text] [Related]
17. Studies on the synthesis of chemotherapeutics. 10. Synthesis and antitumor activity of N-acyl- and N-(alkoxycarbonyl)-5-fluorouracil derivatives.
Kametani T; Kigasawa K; Hiiragi M; Wakisaka K; Haga S; Nagamatsu Y; Sugi H; Fukawa K; Irino O; Yamamoto T; Nishimura N; Taguchi A; Okada T; Nakayama M
J Med Chem; 1980 Dec; 23(12):1324-9. PubMed ID: 7452684
[TBL] [Abstract][Full Text] [Related]
18. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
Klubes P; Cerna I
Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
[TBL] [Abstract][Full Text] [Related]
19. Novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21: antitumor activity and effect on humoral immune response in mice.
Mori H; Nakayama K; Maeda D; Nagai H; Koda A; Kita J; Kaku Y
Cancer Chemother Pharmacol; 1994; 34(3):216-24. PubMed ID: 8004754
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil derivatives. X. Synthesis and antitumor activities of alpha-alkoxyalkyl-5-fluorouracils.
Ozaki S; Watanabe Y; Hoshiko T; Nagase T; Ogasawara T; Furukawa H; Uemura A; Ishikawa K; Mori H; Hoshi A
Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):150-7. PubMed ID: 3698125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
